Editing the Genome to Cure Genetic Disease

Casebia combines CRISPR/Cas9 expertise and technology from CRISPR Therapeutics with access to deep disease-state knowledge and protein engineering capabilities from Bayer. Our aim: to transform the lives of patients and families affected by genetic disease.

Social Media

At #CasebiaTx, we work with #CRISPR/Cas9 gene editing technology to improve outcomes for patients like Ryanne #raredisease #hemophiliaA
https://t.co/IlO6r1uGUJ

Joint Statement from @CRISPRTX on U.S Federal Circuit Decision Upholding the Ruling by U.S. Patent and Trademark Office in Interference Proceeding Relating to #CRISPR/Cas9 Genome Editing Technology https://t.co/uH0s83ZCxM

See us on Twitter